Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DNAFirst: Primary Screening for Down Syndrome by Maternal Plasma DNA

NCT01966991 is registered in ClinicalTrials.gov with Women and Infants Hospital of Rhode Island as lead sponsor.

NCT NCT01966991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01966991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DNAFirst: Primary Screening for Down Syndrome by Maternal Plasma DNA
Lead sponsor
Women and Infants Hospital of Rhode Island
Phase
Observational
Overall status
Completed
Start date
June 30, 2014
Completion date
December 31, 2015
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

monosomy x, trisomy 13, trisomy 18, trisomy 21